Stop outsourcing, start partnering: Redefining value in global clinical trial execution

In this webinar, Sheng Cui, Chief Manufacturing Officer at NewAmsterdam Pharma, and Luke Willson, Sr. Director of Biotech Commercial Operations at Thermo Fisher Scientific, explore how rethinking the CDMO relationship enabled NewAmsterdam Pharma to manage 11 global studies across 51 countries—while operating with a lean internal team.

You’ll gain insight into how they:

• Reframed the CDMO as a value-driving partner, not just a supplier
• Used real-time forecasting and simulation tools to align supply with actual patient enrollment
• Avoided delays, reduced waste, and maintained 100% on-time delivery
• Balanced cost, risk, and quality—without compromising patient access

Join us to explore what redefining value really looks like in practice, and why the future of clinical execution depends on stronger, more strategic partnerships.